Expression of the dermatomyositis autoantigen Mi-2 in regenerating muscle

Arthritis and Rheumatism

Volumn 60, Issue 12, 2009, Pages 3784-3793

  Mammen, Andrew L ^a   Casciola Rosen, Livia A ^a   Hall, John C ^a   Christopher Stine, Lisa ^a   Corse, Andrea M ^a   Rosen, Antony ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOTOXIN; HISTONE DEACETYLASE; MI 2 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DERMATOMYOSITIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; MOUSE; MUSCLE BIOPSY; MUSCLE DEVELOPMENT; MUSCLE INJURY; MUSCLE REGENERATION; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; CARDIOTOXINS; CELL DIFFERENTIATION; CELLS, CULTURED; DERMATOMYOSITIS; DISEASE MODELS, ANIMAL; HUMANS; MI-2 NUCLEOSOME REMODELING AND DEACETYLASE COMPLEX; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; MYOBLASTS; REGENERATION;

EID: 73249151002     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24977     Document Type: Article

References (25)

1. Suber TL, Casciola-Rosen L, Rosen A. Mechanisms of disease: autoantigens as clues to the pathogenesis of myositis. Nat Clin Pract Rheumatol 2008;4:201-9.
2. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003;362:971-82.
3. Christopher-Stine L, Plotz PH. Adult inflammatory myopathies. Best Pract Res Clin Rheumatol 2004;18:331-44.
4. Ghirardello A, Zampieri S, Iaccarino L, Tarricone E, Bendo R, Gambari PF, et al. Anti-Mi-2 antibodies. Autoimmunity 2005;38: 79-83.
5. Targoff IN, Reichlin M. The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum 1985;28:796-803.
6. Reichlin M, Mattioli M. Description of a serological reaction characteristic of polymyositis. Clin Immunol Immunopathol 1976; 5:12-20.
7. Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991;70:360-74.
8. Hengstman GJ, Vree Egberts WT, Seelig HP, Lundberg IE, Moutsopoulos HM, Doria A, et al. Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen. Ann Rheum Dis 2006;65:242-5.
9. Targoff IN. Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies. Rheum Dis Clin North Am 2002;28:859-90.
10. Casciola-Rosen L, Nagaraju K, Plotz P, Wang K, Levine S, Gabrielson E, et al. Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. J Exp Med 2005;21;201:591-601.
11. Solari F, Ahringer J. NURD-complex genes antagonise Rasinduced vulval development in Caenorhabditis elegans. Curr Biol 2000;24;10:223-6.
12. Kashiwagi M, Morgan BA, Georgopoulos K. The chromatin remodeler Mi-2beta is required for establishment of the basal epidermis and normal differentiation of its progeny. Development 2007;134:1571-82.
13. Nagaraju K, Casciola-Rosen L, Rosen A, Thompson C, Loeffler L, Parker T, et al. The inhibition of apoptosis in myositis and in normal muscle cells. J Immunol 2000;164:5459-65.
14. Yaffe D, Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 1977;270: 725-7.
15. Washington University Neuromuscular Disease Center. Neuromuscular clinical laboratory: hematoxylin & eosin (H & E) stain protocol. URL: neuromuscular.wustl.edu/pathol/histol/h&e.htm.
16. Casciola-Rosen LA, Anhalt GJ, Rosen A. DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med 1995;182:1625-34.
17. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994; 179:1317-30.
18. Harris JB. Myotoxic phospholipases A2 and the regeneration of skeletal muscles. Toxicon 2003;42:933-45.
19. Cooper ST, Maxwell AL, Kizana E, Ghoddusi M, Hardeman EC, Alexander IE, et al. C2C12 co-culture on a fibroblast substratum enables sustained survival of contractile, highly differentiated myotubes with peripheral nuclei and adult fast myosin expression. Cell Motil Cytoskeleton 2004;58:200-11.
20. Seelig HP, Moosbrugger I, Ehrfeld H, Fink T, Renz M, Genth E. The major dermatomyositis-specific Mi-2 autoantigen is a presumed helicase involved in transcriptional activation. Arthritis Rheum 1995;38:1389-99.
21. Seelig HP, Renz M, Targoff IN, Ge Q, Frank MB. Two forms of the major antigenic protein of the dermatomyositis-specific Mi-2 autoantigen [letter]. Arthritis Rheum 1996;39:1769-71.
22. Zhang Y, LeRoy G, Seelig HP, Lane WS, Reinberg D. The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities. Cell 1998;95:279-89.
23. Kehle J, Beuchle D, Treuheit S, Christen B, Kennison JA, Bienz M, et al. dMi-2, a hunchback-interacting protein that functions in polycomb repression. Science 1998;282:1897-900.
24. Salvini TF, Morini CC, Selistre de Araujo HS, Ownby CL. Long-term regeneration of fast and slow murine skeletal muscles after induced injury by ACL myotoxin isolated from Agkistrodon contortrix laticinctus (broad-banded copperhead) venom. Anat Rec 1999;254:521-33.
25. Matsuura T, Li Y, Giacobino JP, Fu FH, Huard J. Skeletal muscle fiber type conversion during the repair of mouse soleus: potential implications for muscle healing after injury. J Orthop Res 2007; 25:1534-40.